Tag Archives: Arrowhead Pharmaceuticals Inc.

Healthcare stocks rattled by Trump’s threat to force public pricing disclosure across the entire sector. The top winners, losers, and reasons why.

President Trump is expected to sign an executive order this week that would require for the first time disclosure of prices across the healthcare industry, in a move that officials… Read more »

Weekly Medical Stock Spotlight: 3 big winners and 2 total duds.

1) ProQR Therapeutics NV (Nasdaq:PRQR) led advancing issues on the Labor Day-shortened week, soaring 107% over the week to $15.80 on Friday (August 31, 2018). The upward move came after the… Read more »

Top 1H health-sector winners and losers; buy/sell opinion.

The News: Now that we’ve reached the end of the first half of 2018, there might be some interesting surprises–both good and not-so-good–for those equity investors interested in who’s being… Read more »

Arrowhead Pharma obliterated after ditching Hep B candidate; oh, that’s right, biotechs are risky

Shares of Arrowhead Pharmaceuticals Inc. (Pasadena CA) cratered 69% to $1.44 last week (November 28 to December 2, 2016) after the company said it would stop developing all drugs being… Read more »